The Recent Development of Farnesyltransferase Inhibitors as Anticancer and Antimalarial Agents

E-ISSN： 1875-5607|15|10|837-857

ISSN： 1389-5575

Source： Mini Reviews in Medicinal Chemistry, Vol.15, Iss.10, 2015-08, pp. : 837-857

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inhibitors of Protein Farnesyltransferase as Novel Anticancer Agents

Current Topics in Medicinal Chemistry, Vol. 2, Iss. 3, 2002-03 ,pp. : 303-323

Bentham Science Publishers

Access to resources Recommend Favorite

Farnesyltransferase inhibitors:a cell signalling approach to the design of efficacious anticancer agents

By Sebolt-Leopold J.

Expert Opinion on Emerging Drugs, Vol. 3, Iss. 1, 1998-06 ,pp. : 271-278

Informa Healthcare

Access to resources Recommend Favorite

CA 1 A 2 X-competitive inhibitors of farnesyltransferase as anti-cancer agents

By Omer C.A. Kohl N.E.

Trends in Pharmacological Sciences, Vol. 18, Iss. 11, 1997-11 ,pp. : 437-445

Elsevier

Access to resources Recommend Favorite

Recent Progress in the Development of Histone Deacetylase Inhibitors as Anti-Cancer Agents

Mini Reviews in Medicinal Chemistry, Vol. 13, Iss. 14, 2013-12 ,pp. : 1999-2013

Bentham Science Publishers

Access to resources Recommend Favorite

Recent Advances in the Development of Thioredoxin Reductase Inhibitors as Anticancer Agents

Current Drug Targets, Vol. 13, Iss. 11, 2012-10 ,pp. : 1432-1444

Bentham Science Publishers

Access to resources Recommend Favorite